Animal Cells TRIZ Cases

Magnetic levitation forms scaffold-free 3D cell cultures, while fractal image analysis tracks viability and cell interactions in real time.

A DLL3-CD3 bispecific antibody redirects T cells to kill SCLC tumors, addressing chemoresistance and limits of DLL3 antibody-drug conjugates.

Dual-epitope anti-CCL2 antibodies improve binding and accelerate CCL2 clearance, supporting lower-dose treatment of cancer and inflammatory disease.

Direct tissue-derived vesicle isolation and membrane mass spectrometry reveal clinically relevant disease biomarkers missed by cell-line markers.

Adsorptive inorganic particles promote fast, low-cost spheroid formation in cell suspensions without special scaffolds, vessels, or media.

Machine learning ranks unknown microelectrode waveforms against teacher data to speed toxicity evaluation and reduce subjective selection.

Coating culture surfaces with isolated mitochondria enables efficient cell uptake with minimal damage, avoiding complex microinjection steps.

A dual PEG-polypeptide network hydrogel gels within 10 seconds, adheres to tissue, and maintains cell compatibility on complex surfaces.

Headspace VOC patterns replace gene and protein assays to detect cancer cell signaling and monitor metastasis or therapy response.

Combining stepwise centrifugation, density gradients, and size-exclusion chromatography improves biological sample resolution without long processing times.

Software-controlled valve arrays automate tissue-specific cell isolation, reducing manual error, contamination risk, and processing time.

A DLL3-targeting and CD3-binding antibody boosts T cell synapse formation and cytotoxicity against SCLC cells with chemoresistant relapse.

Fully human CD276-binding antibodies improve tumor targeting and avoid HAMA reactions, enabling safer CAR-T and BiTE therapy.

Alternating spacer and immobilization layers create uniform medium flow, reproducible packing, and high-density cell growth in bioreactors.

Preconditioning agents raise IL-7, IL-15 and related cytokines so clinicians can time T cell therapy for stronger proliferation and response.

Serum-free bioreactor cultivation improves cell biomass yield for food while lowering contamination risk, energy use, and harvest complexity.

Structured spacer and immobilization layers create uniform medium flow, lower pressure drop, and improve reproducible high-density cell growth.

A depressurizable outer package removes air bubbles from microstructured culture bags during vacuum packaging, cutting labor, equipment, and contamination risk.

MHC-binding tumor peptides such as KIQEILTQV drive T-cell targeting of cancer cells while reducing off-target effects of broader immunotherapy.

MHC-binding peptide combinations target tumor-associated epitopes to activate CD4 and CD8 T cells for esophageal cancer with fewer side effects.